Pyruvate dehydrogenase kinases as therapeutic targets for...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/54 (2006.01) A61K 31/12 (2006.01) A61K 31/16 (2006.01) A61K 31/19 (2006.01) A61K 31/495 (2006.01) A61K 31/7088 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07H 21/00 (2006.01) C12N 5/10 (2006.01) C12N 15/11 (2006.01) C12N 15/53 (2006.01) C12N 15/63 (2006.01) C12Q 1/02 (2006.01) C12Q 1/18 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) C12N 9/02 (2006.01) C12N 9/12 (2006.01)

Patent

CA 2584057

The invention provides therapeutic and prophylactic compounds and methods for altering the activity of pyruvate dehydrogenase kinase (e.g. PDK1, PDK2, PDK3, PDK4). Such therapies are useful for the treatment of neoplasia. The invention further provides therapeutic and prophylactic compounds and methods of altering pyruvate dehydrogenase activity to treat or prevent cell death related to ischemia.

L'invention concerne des composés thérapeutiques et prophylactiques ainsi que des méthodes permettant de modifier l'activité de la pyruvate déshydrogénase kinase (par exemple, PDK1, PDK2, PDK3, PDK4). Ces thérapies sont utiles pour le traitement de la néoplasie. L'invention concerne également des composés thérapeutiques et prophylactiques et des méthodes permettant de modifier l'activité de la pyruvate déshydrogénase kinase afin de traiter ou de prévenir la mort cellulaire associée à l'ischémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyruvate dehydrogenase kinases as therapeutic targets for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyruvate dehydrogenase kinases as therapeutic targets for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyruvate dehydrogenase kinases as therapeutic targets for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1356895

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.